T-Cell Immunotherapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell Immunotherapy Overall Market Size
2.1 Global T-Cell Immunotherapy Market Size: 2023 VS 2030
2.2 Global T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Immunotherapy Players in Global Market
3.2 Top Global T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Immunotherapy Companies in Global Market, by Revenue in 2023
3.5 Global Companies T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell Immunotherapy Market Size Markets, 2023 & 2030
4.1.2 CAR-T
4.1.3 TCR
4.1.4 TIL Therapies
4.2 By Type - Global T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global T-Cell Immunotherapy Revenue, 2019-2024
4.2.2 By Type - Global T-Cell Immunotherapy Revenue, 2025-2030
4.2.3 By Type - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell Immunotherapy Market Size, 2023 & 2030
5.1.2 Stomach Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophagus Cancer
5.1.6 Pancreatic Cancer
5.1.7 Others
5.2 By Application - Global T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global T-Cell Immunotherapy Revenue, 2019-2024
5.2.2 By Application - Global T-Cell Immunotherapy Revenue, 2025-2030
5.2.3 By Application - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global T-Cell Immunotherapy Market Size, 2023 & 2030
6.2 By Region - Global T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global T-Cell Immunotherapy Revenue, 2019-2024
6.2.2 By Region - Global T-Cell Immunotherapy Revenue, 2025-2030
6.2.3 By Region - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America T-Cell Immunotherapy Revenue, 2019-2030
6.3.2 US T-Cell Immunotherapy Market Size, 2019-2030
6.3.3 Canada T-Cell Immunotherapy Market Size, 2019-2030
6.3.4 Mexico T-Cell Immunotherapy Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe T-Cell Immunotherapy Revenue, 2019-2030
6.4.2 Germany T-Cell Immunotherapy Market Size, 2019-2030
6.4.3 France T-Cell Immunotherapy Market Size, 2019-2030
6.4.4 U.K. T-Cell Immunotherapy Market Size, 2019-2030
6.4.5 Italy T-Cell Immunotherapy Market Size, 2019-2030
6.4.6 Russia T-Cell Immunotherapy Market Size, 2019-2030
6.4.7 Nordic Countries T-Cell Immunotherapy Market Size, 2019-2030
6.4.8 Benelux T-Cell Immunotherapy Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia T-Cell Immunotherapy Revenue, 2019-2030
6.5.2 China T-Cell Immunotherapy Market Size, 2019-2030
6.5.3 Japan T-Cell Immunotherapy Market Size, 2019-2030
6.5.4 South Korea T-Cell Immunotherapy Market Size, 2019-2030
6.5.5 Southeast Asia T-Cell Immunotherapy Market Size, 2019-2030
6.5.6 India T-Cell Immunotherapy Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America T-Cell Immunotherapy Revenue, 2019-2030
6.6.2 Brazil T-Cell Immunotherapy Market Size, 2019-2030
6.6.3 Argentina T-Cell Immunotherapy Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T-Cell Immunotherapy Revenue, 2019-2030
6.7.2 Turkey T-Cell Immunotherapy Market Size, 2019-2030
6.7.3 Israel T-Cell Immunotherapy Market Size, 2019-2030
6.7.4 Saudi Arabia T-Cell Immunotherapy Market Size, 2019-2030
6.7.5 UAE T-Cell Immunotherapy Market Size, 2019-2030
7 T-Cell Immunotherapy Companies Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Company Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune T-Cell Immunotherapy Major Product Offerings
7.1.4 Adaptimmune T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.1.5 Adaptimmune Key News & Latest Developments
7.2 Altor Bioscience Corporation
7.2.1 Altor Bioscience Corporation Company Summary
7.2.2 Altor Bioscience Corporation Business Overview
7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Major Product Offerings
7.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.2.5 Altor Bioscience Corporation Key News & Latest Developments
7.3 Cellectis
7.3.1 Cellectis Company Summary
7.3.2 Cellectis Business Overview
7.3.3 Cellectis T-Cell Immunotherapy Major Product Offerings
7.3.4 Cellectis T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.3.5 Cellectis Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics T-Cell Immunotherapy Major Product Offerings
7.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Kite Pharma
7.5.1 Kite Pharma Company Summary
7.5.2 Kite Pharma Business Overview
7.5.3 Kite Pharma T-Cell Immunotherapy Major Product Offerings
7.5.4 Kite Pharma T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.5.5 Kite Pharma Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis T-Cell Immunotherapy Major Product Offerings
7.6.4 Novartis T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.6.5 Novartis Key News & Latest Developments
7.7 Takara Bio
7.7.1 Takara Bio Company Summary
7.7.2 Takara Bio Business Overview
7.7.3 Takara Bio T-Cell Immunotherapy Major Product Offerings
7.7.4 Takara Bio T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.7.5 Takara Bio Key News & Latest Developments
7.8 Unum Therapeutics
7.8.1 Unum Therapeutics Company Summary
7.8.2 Unum Therapeutics Business Overview
7.8.3 Unum Therapeutics T-Cell Immunotherapy Major Product Offerings
7.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue in Global Market (2019-2024)
7.8.5 Unum Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. T-Cell Immunotherapy Market Drivers in Global Market
Table 3. T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of T-Cell Immunotherapy in Global Market
Table 5. Top T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2023)
Table 6. Global T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global T-Cell Immunotherapy Revenue Share by Companies, 2019-2024
Table 8. Global Companies T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2025-2030
Table 30. Adaptimmune Company Summary
Table 31. Adaptimmune T-Cell Immunotherapy Product Offerings
Table 32. Adaptimmune T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 33. Adaptimmune Key News & Latest Developments
Table 34. Altor Bioscience Corporation Company Summary
Table 35. Altor Bioscience Corporation T-Cell Immunotherapy Product Offerings
Table 36. Altor Bioscience Corporation T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 37. Altor Bioscience Corporation Key News & Latest Developments
Table 38. Cellectis Company Summary
Table 39. Cellectis T-Cell Immunotherapy Product Offerings
Table 40. Cellectis T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 41. Cellectis Key News & Latest Developments
Table 42. Juno Therapeutics Company Summary
Table 43. Juno Therapeutics T-Cell Immunotherapy Product Offerings
Table 44. Juno Therapeutics T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 45. Juno Therapeutics Key News & Latest Developments
Table 46. Kite Pharma Company Summary
Table 47. Kite Pharma T-Cell Immunotherapy Product Offerings
Table 48. Kite Pharma T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 49. Kite Pharma Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis T-Cell Immunotherapy Product Offerings
Table 52. Novartis T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 53. Novartis Key News & Latest Developments
Table 54. Takara Bio Company Summary
Table 55. Takara Bio T-Cell Immunotherapy Product Offerings
Table 56. Takara Bio T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 57. Takara Bio Key News & Latest Developments
Table 58. Unum Therapeutics Company Summary
Table 59. Unum Therapeutics T-Cell Immunotherapy Product Offerings
Table 60. Unum Therapeutics T-Cell Immunotherapy Revenue (US$, Mn) & (2019-2024)
Table 61. Unum Therapeutics Key News & Latest Developments
List of Figures
Figure 1. T-Cell Immunotherapy Segment by Type in 2023
Figure 2. T-Cell Immunotherapy Segment by Application in 2023
Figure 3. Global T-Cell Immunotherapy Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global T-Cell Immunotherapy Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global T-Cell Immunotherapy Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2023
Figure 8. By Type - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 9. By Application - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 10. By Type - Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 12. By Application - Global T-Cell Immunotherapy Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 14. By Region - Global T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 15. By Country - North America T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 16. US T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 17. Canada T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 20. Germany T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 21. France T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 23. Italy T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 24. Russia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 28. China T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 29. Japan T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 32. India T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 34. Brazil T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa T-Cell Immunotherapy Revenue Market Share, 2019-2030
Figure 37. Turkey T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 38. Israel T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 40. UAE T-Cell Immunotherapy Revenue, (US$, Mn), 2019-2030
Figure 41. Adaptimmune T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Altor Bioscience Corporation T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Cellectis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Juno Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Kite Pharma T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novartis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Takara Bio T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Unum Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
